Foresite Capital Management IV, LLC
Foresite Capital Management IV, LLC is an investment fund managed by Foresite Capital, a multi-stage healthcare and life sciences investment firm headquartered in Larkspur, California. The firm was founded in 2011 and specializes in data- and science-driven strategies focusing on healthcare and life sciences companies, serving institutional investors including university endowments, pension funds, insurance companies, and foundations. Foresite Capital employs a multidisciplinary team and manages over $2 billion in assets across multiple funds. Fund IV, specifically, raised $668 million, expanding the firm's reach and expertise.
Investment Strategy
Foresite Capital Management IV employs a rigorous, data- and science-driven investment approach, funding promising businesses in areas of great unmet need within healthcare and life sciences. The firm invests in companies from seed stage through public markets, leveraging the expertise of scientists, clinicians, analysts, and engineers to derive meaningful insights from complex healthcare data. The focus is on supporting innovative therapeutics, diagnostics, and healthcare technologies through a multidisciplinary investment team.
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
P PHVS | Pharvaris N.V. | 62.70% | $77.6M | 4,410,581 | $25.74 | $17.60 | +$8.4M |
M MAZE | Maze Therapeutics Inc | 20.93% | $25.9M | 2,111,919 | $11.01 | $12.27 | +$2.7M |
L LYEL | Lyell Immunopharma, Inc. | 5.72% | $7.1M | 800,399 | $8.84 | $8.84 | +$7.1M |
X XENE | Xenon Pharmaceuticals Inc | 4.05% | $5.0M | 160,000 | $31.30 | $31.30 | +$5.0M |
K KURA | Kura Oncology, Inc. | 3.81% | $4.7M | 816,882 | $20.81 | $5.77 | -$2.6M |